Resources from the same session
Welcome and Introduction
Presenter: Eric Van Cutsem, Belgium; Josep Tabernero, Spain; Michel Ducreux, France
Session: Session I: Opening Session
First-line panitumumab versus bevacizumab in combination with mFOLFOX6 for RAS wild-type metastatic colorectal cancer: PARADIGM trial results
Presenter: Kei Muro, Japan
Session: Session I: Opening Session
Resources:
Slides
Discussant: LBA 0-9, LBA 0-10
Presenter: Ryan Corcoran, United States
Session: Session I: Opening Session
Resources:
Slides